Parataxis Holdings, an affiliate of digital asset-focused funding agency Parataxis Capital Administration, is ready to launch a Bitcoin-native treasury platform within the South Korean public market.
The agency introduced on June 20 that it had entered a definitive settlement to speculate 29 billion South Korean received ($18.5 million) into Bridge Biotherapeutics, a publicly traded biotech firm.
Following the acquisition, Parataxis will take a controlling curiosity within the agency, which will probably be renamed Parataxis Korea and repurposed as a treasury car for institutional Bitcoin (BTC) publicity.
“Impressed by the rising curiosity in BTC treasury methods seen in firms like Technique within the US and Metaplanet in Japan, we imagine institutional curiosity on this house is growing globally,” mentioned Andrew Kim, Companion at Parataxis Capital. “We see South Korea as an vital market within the evolution of BTC adoption.”
Kim added that the agency’s intent is to assist institutional entry to Bitcoin whereas emphasizing sound company governance and disciplined capital administration.
At the moment, Bitcoin exchange-traded funds (ETFs) and institutional crypto investments are banned in South Korea.
Nonetheless, the nation’s Monetary Companies Fee (SFC) has allowed 3,500 companies {and professional} buyers to open “real-name” accounts within the first half of 2025 as a part of a pilot program aiming to regularly allow institutional digital asset investments.
Associated: ‘Apple can buy Bitcoin,’ Saylor says, as share buyback disappoints
Parataxis’ new platform was introduced over every week after the New York-headquartered agency introduced plans to go public by way of a $200 million particular acquisition firm, Cointelegraph reported on June 10.
The Parataxis announcement comes amid a wave of company Bitcoin adoption. Greater than 237 public firms now maintain Bitcoin on their stability sheets, up from 124 companies simply weeks earlier, representing roughly 3.96% of the entire BTC provide, in response to BitcoinTreasuries.NET.
Associated: Nasdaq-listed Mercurity Fintech to lift $800M for Bitcoin treasury
Inventory rallies observe treasury bulletins
Bridge Biotherapeutics’ inventory rose greater than 20% on the each day chart following information of the acquisition, in response to TradingView knowledge. Nonetheless, the biotech agency’s inventory stays down 74% year-to-date and over 90% from its five-year excessive.
Based in 2015 and listed on the Korean Securities Sellers Automated Quotations in 2019, Bridge Biotherapeutics develops therapeutics for the remedy of ulcerative colitis, fibrotic ailments and most cancers.
Earlier at this time, London-based synthetic intelligence options agency Pri0r1ty Intelligence Group introduced plans to undertake Bitcoin as a reserve asset and cost resolution with out disclosing a direct Bitcoin funding.
Following the announcement, the agency’s inventory worth rose over 84% on the each day chart, reversing its one-year downtrend of 32%, Google Finance knowledge reveals.
Not all firms are benefiting equally. GameStop shares fell greater than 22% after the online game retailer elevated its convertible be aware providing to $2.25 billion, which some analysts interpreted as a sign of additional crypto-related investments.
Journal: Arthur Hayes $1M Bitcoin tip, altcoins ‘highly effective rally’ looms: Hodler’s Digest, Might 11 – 17
